MDxHealth SA (NASDAQ: MDXH) reported Q2 EPS of ($0.12), $0.45 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $6.41 million.

GUIDANCE:

MDxHealth SA sees Q3 2022 revenue of $40-42 million.

For earnings history and earnings-related data on MDxHealth SA (MDXH) click here.